Long COVID
-
healthTargeted Cognitive Therapy Yields Lasting Relief for Long COVID Brain Fog
A randomized trial reveals goal-focused cognitive rehabilitation produces significant and durable improvements in daily function for patients suffering from long COVID-related cognitive impairment.
-
healthCOVID-19 Linked to Elevated Long-Term Risk of Obstructive Sleep Apnea
A large-scale study reveals adults who contracted SARS-CoV-2 are significantly more likely to develop obstructive sleep apnea, with cardiovascular complications spiking in high-risk subgroups.
-
healthACTIV-6 Trial: Metformin Reduces Clinician-Diagnosed Long COVID Risk
The ACTIV-6 randomized trial reveals metformin lowers clinician-diagnosed long COVID by 50% in immune outpatients, despite missing primary endpoints for patient-reported symptom prevention at six months.
-
healthOnline Singing Program Eases Long COVID Symptoms in UK Study
A large UK study finds ENO Breathe, an online singing program, improves quality of life and reduces breathlessness and anxiety in long COVID patients.
-
healthLong-Hantavirus: Survivors Face Months of Lingering Symptoms
New research shows hantavirus survivors suffer persistent symptoms months after infection, revealing a long-recovery phase similar to Long COVID.
-
healthLong COVID Prevalence Plateaus in U.S. Adults, Study Finds
New data shows long COVID rates stable from 2023-2024, with persistent functional limitations affecting daily activities for millions.
-
healthLong COVID's Economic Toll: Billions Lost Annually
A new study reveals the staggering annual economic cost of Long COVID across OECD countries, projected to reach over $135 billion, impacting GDP and healthcare systems.
-
healthLong COVID's Staggering Economic Toll: OECD Faces €116 Billion Annual Hit
New OECD report reveals the substantial, long-term economic burden of Long COVID on member countries, projecting billions in annual losses and highlighting the need for sustained attention.